Listening for More: When Clinical Conversations Become Clinical Intelligence

Clinical AI is moving beyond capturing clinical conversations to ensuring clinicians can make sense of and utilize the information surrounding it. In this episode, Russ Branzell, President and CEO of CHIME, is joined by Dr. Nadim Ilbawi, Vice President of Clinical Success & Strategy at Abridge, to explore what this evolution means for clinicians, patients, and the health systems implementing these capabilities at scale.

From surfacing relevant clinical context at the point of care to evaluating accuracy, performance, and measurable impact, the conversation examines what leaders should consider as AI becomes more deeply integrated into clinical workflows. Dr. Ilbawi also explores how EHR integration, data quality, organizational readiness, and governance can shape whether clinical AI delivers meaningful value across an enterprise.

Key Takeaways:

• What healthcare leaders should evaluate as AI takes on a more consequential role in clinical workflows.

• Which integration, data quality, workflow, and organizational factors can determine whether clinical AI scales effectively across a health system.

• How leaders can measure clinical AI’s impact across clinician experience, patient experience, quality, and financial outcomes.

• Which priorities can help health systems build a clinical AI strategy that creates meaningful, sustainable value.